መነሻ › ማይሎዲስፕላስቲክ ሲንድሮሞች › North Carolina › Durham
በDurham፣ NC ለማይሎዲስፕላስቲክ ሲንድሮሞች የሚደረጉ ክሊኒካዊ ጥናቶች
ለማይሎዲስፕላስቲክ ሲንድሮሞች የሚደረጉ 14 ጥናቶች በDurham እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ማይል ርቀት
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Duke University Medical Center, Durham
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of North Carolina at Chapel Hill, Chapel Hill · 10 ማይል ርቀት
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Unc Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ማይል ርቀት
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ማይል ርቀት
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of North Carolina at Chapel Hill, Chapel Hill · 10 ማይል ርቀት
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Duke Cancer Institute, Durham
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site, Durham
- Research Site, Chapel Hill · 10 ማይል ርቀት
Registry of Older Patients With Cancer
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 ማይል ርቀት
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Duke University, Durham
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Duke University, Durham
- UNC Hospital, Chapel Hill · 10 ማይል ርቀት
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Duke Cancer Center, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 ማይል ርቀት
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 ማይል ርቀት
በሌሎች ከተሞች ለማይሎዲስፕላስቲክ ሲንድሮሞች የሚደረጉ ጥናቶች
- Houston, TX43 ጥናቶች
- Baldwin Park, CA26 ጥናቶች
- New York City, NY21 ጥናቶች
- Seattle, WA21 ጥናቶች
- Washington, DC20 ጥናቶች
- Tampa, FL19 ጥናቶች
- Boston, MA19 ጥናቶች
- Miami, FL17 ጥናቶች
- Columbus, OH14 ጥናቶች
- St. Louis, MO13 ጥናቶች
- Atlanta, GA13 ጥናቶች
- Chicago, IL13 ጥናቶች
በDurham ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር64 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)58 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር39 ጥናቶች
- Multiple Myeloma37 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ33 ጥናቶች
- Metastatic Cancer33 ጥናቶች
- የፕሮስቴት ካንሰር32 ጥናቶች
- የሳንባ ካንሰር32 ጥናቶች
- የኮሎሬክታል ካንሰር28 ጥናቶች
- የእንቁላል ካንሰር27 ጥናቶች
- ክሮኒክ ሊምፎሳይቲክ ሉኬሚያ27 ጥናቶች
- የልብ ድካም26 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።